PRRT2 and breast neoplasm: We and other groups found that PKCθ was highly expressed in estrogen receptor negative (ER−) human breast tumors at transcript [47,48] and protein levels [49], whereas it was not expressed in normal breast epithelia and weakly expressed in ER+ breast tumors.